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Primary cardiac lymphoma (PCL) is very rare, and is extremely challenging to diagnose due to nonspecific
symptoms. When discovered, the right atrium and ventricle are most commonly affected, while diffuse cardiac
involvement is uncommon. PCL is fatal unless promptly diagnosed and treated. Herein, we present the case of a
36-year-old immunocompetent male who presented with a 5-year history of non-specific chest symptoms and was
diagnosed with primary diffuse cardiac large B-cell lymphoma involving the entire heart.
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Primary cardiac lymphoma (PCL) is a very rare disorder
that presents with nonspecific symptoms, making diag-
nosis challenging [1]. The disorder accounts for approxi-
mately 1% of primary cardiac tumors and 0.5% of
extranodal lymphomas, occurs three times more com-
monly in females than males with a median age at diag-
nosis of 64 years, and usually involves the right atrium
and ventricle [2]. We herein present the case of a 36-
year-old immunocompetent male with a 5-year history
of worsening chest symptoms who was diagnosed with a
primary diffuse cardiac large B-cell lymphoma.Case presentation
A 36-year-old immunocompetent male with history of
gastroesophageal reflux presented with a 5-year history
of dyspnea on exertion, chest tightness, shortness of
breath, palpitations, and back pain. Physical exam
revealed a heart murmur, ECG showed a Mobitz I AV
block, RBBB, and right axis deviation, and chest radio-
graph demonstrated an enlarged heart. Laboratory stud-
ies were normal.
Transthoracic echocardiography revealed heteroge-
neous infiltration involving the aortic root and four* Correspondence: Drljr0821@gmail.com
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reproduction in any medium, provided the orchambers with marked biventricular wall thickening and
moderate pericardial effusion (Figure 1A, B). The infil-
trated myocardium stiffened the heart and significantly
impaired systolic and diastolic functions. Computed
tomography (CT) revealed a diffuse soft tissue density
wrapping around the great vessels.
The patient was admitted and subsequently underwent
endomyocardial biopsy prior to initiating treatment.
Immunohistopathology showed infiltration of the myo-
cardial fibers by atypical intermediate to large-sized
lymphoid cell (Figure 2) that were positive for CD20,
CD10, CD79, CD19, and LCA. Bone marrow biopsy
revealed normocellular bone marrow, without evidence
of lymphoma infiltrate. The final diagnosis was primary
diffuse cardiac large B-cell lymphoma.
The patient subsequently received chemotherapy. The 1st
cycle consisted of cyclophosphamide/vincristine/prednisol-
one (COP), omitting doxorubicin due to concern of heart
toxicity given the heart block. Doxorubicin was added for
the 2nd cycle (CHOP), and rituximab was added for the 3rd
through 7th cycles (R-CHOP). CT showed diminished car-
diac size after the first cycle. After the 2nd cycle, the patient
developed ventricular tachycardia and received synchro-
nized cardioversion with resultant 1st degree AV block. He
then experienced paroxysmal ventricular tachycardia after
the 4th cycle that responded to cardioversion.
The patient responded well to chemotherapy. ECG
6 months after treatment showed normal sinus rhythm.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Echocardiography before treatment (left section, A: parasternal long axis and B:parasternal short axis) revealed
heterogeneous infiltration involving the aortic root, and markedly increased left and right ventricular wall thickness (*). Moderate
pericardial effusion (15.2 mm) was also noted (†). Six months after treatment (right section, C: parasternal long axis and D: parasternal short axis),
reduced thickening of the myocardium and resolution of pericardial effusion were noted.
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bal systolic and diastolic functions, with significant re-
duction of myocardial thickness and resolution of
pericardial effusion (Figure 1C, D).Figure 2 Histological and immunohistochemical staining of the endom
to large-sized lymphoid cell infiltration in myocardium; E: Hematoxylin
(magnification at 400×). G: anti-CD20 staining (magnification at 400×). H: aDiscussion
The incidence of primary cardiac tumors is approxi-
mately 0.02%, and PCLs account for approximately 1%
of primary cardiac tumors and the majority is diffuseyocardial biopsy prior to treatment revealed atypical, intermediate
and eosin staining (magnification at 400×). F: anti-CD19 staining
nti-CD79 staining (magnification at 400×).
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by Miguel and Bestetti [4] for reports pertaining to the “clin-
ical aspects, diagnosis, clinical course, or treatment” of PCL
found 61 articles. Based on their review, the authors
reported that PCL occurs more frequently in immunocom-
promised patients and those taking immunosuppressant
drugs, cardiac transplant recipients, and predominantly male
AIDS patients. In addition, PCL usually manifests after the
fifth decades of life, and usually affects the right side of the
heart. Though symptoms are non-specific and vary with the
locations in the hearts affected, the most common clinical
manifestations are pericardial effusion, heart failure, and AV-
block [4]. Diagnosis of PCL is often delayed due to non-
specific symptoms, and the prognosis is poor with a reported
median survival of 7 months after initiation of treatment [5,
6], though improved survival has been seen with the
addition of rituximab to chemotherapy regimens [4].
The initial symptoms of PCL are non-specific and can
be suggestive of many disorders including heart failure,
infection, arrhythmias, and emboli [1]. Though PCL is
typically seen in older patients and is associated with an
immunocompromised state [1, 2], our case illustrates
that the condition can occur in young, otherwise healthy
individuals. Interestingly, our patient presented with dif-
fuse cardiac infiltration involving the entire heart, rather
than the more commonly reported presentation involv-
ing single site such as the right atrium/ventricle [1, 2].
Imaging modalities including echocardiography, CT, and
magnetic resonance imaging (MRI) are useful for illustrat-
ing the cardiac involvement in PCL; however, histopatho-
logical examination of biopsied or surgical specimen is
needed for diagnosis [1]. While in the past PCL was almost
universally fatal, advances in imaging and anthracycline-
based chemotherapy have markedly improved survival,
though the median survival remains low [2].
Our patient presented with Mobitz I AV block and
RBBB and developed several arrhythmias during treat-
ment. The myocardium infiltrated by lymphoma cells
becomes heterogeneous substrate, which is prone to de-
velop cardiac arrhythmias or conduction disorders [7].
Special attention should be given to high-grade AV
blocks or fatal arrhythmias during treatment of PCL [8].
Unfortunately, indications for placement of pacemaker
or implantable cardioverter defibrillator in patients with
cardiac lymphomas are not straightforward [8]. Given
the high mortality of PCL, and resolution of conduction
disorders and arrhythmias with treatment, device place-
ment is not likely warranted in most cases. Though rare,
cardiac rupture can occur with diffuse cardiac involve-
ment and should be monitored [9].
Conclusions
In summary, PCL can occur in young healthy individuals
and should be considered in the differential diagnosiswhen treatments for more common conditions fail.
Heart block and arrhythmias in PCL with diffuse cardiac
involvement can be severe, and warrant additional vigi-
lance during management.
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